Logo do repositório
 
Publicação

Hyperbaric oxygen therapy in the treatment of late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation

dc.contributor.authorArana Ribeiro, Joana
dc.contributor.authorAlpuim Costa, Diogo
dc.contributor.authorGaio-Lima, Clara
dc.contributor.authorGuilherme Gonçalves-Nobre, José
dc.contributor.authorPortugal Rodrigues, Inês
dc.contributor.authorTrigo Miranda, Mariana
dc.contributor.authorPinho Vaz, Carlos
dc.contributor.authorD’Espiney Amaro, Carla
dc.contributor.authorCamacho, Óscar
dc.contributor.institutionNOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
dc.contributor.pblNature Publishing Group
dc.date.accessioned2024-10-31T23:25:44Z
dc.date.available2024-10-31T23:25:44Z
dc.date.issued2024-12
dc.descriptionFunding Information: We would like to acknowledge our partner, CUF Oncology, for all the support. Publisher Copyright: © The Author(s) 2024.
dc.description.abstractIntroduction: Hemorrhagic cystitis (HC) is a common complication after allogeneic hematopoietic stem cell transplantation (HSCT), characterized by inflammation and bleeding of the bladder. Hyperbaric oxygen therapy (HBOT) has been shown to be effective in the treatment of radiation-induced HC. However, the optimal treatment for HC after allogeneic HSCT has not yet been established. Furthermore, limited research has been conducted on the use of HBOT in this setting. This study aimed to evaluate the effectiveness and safety of HBOT in patients with late-onset HC after allogeneic HSCT. Methods: Twenty-five-year (1998–2022) retrospective analysis performed in all consecutive patients with confirmed late-onset HC after allogeneic HSCT treated with HBOT at two centers in Portugal. Medical records were reviewed for clinical and laboratory features, primary indications for allogeneic HSCT, conditioning regimen, and treatment strategies for HC. Patients received 100% oxygen at 2.1–2.5 atmosphere absolute pressure (ATA) for 70–90-minute periods, once daily, five times per week. Complete clinical response was defined as the absence of macroscopic hematuria sustained for at least 2 weeks, and partial response was described as a downgrading in the severity of HC. Statistical significance was considered for values of p < 0.05. Results: The sample included 61 patients with a mean age of 28.0 (SD 14.2) years, 33 males. Complete response was achieved in 72.1% (n = 44) of patients and partial response in 14.8% (n = 9). Concerning patients with a complete response, the median number of HBOT sessions was 15.5 sessions (IQR 10.0-26.8). Patients treated with 10 or more sessions of HBOT had a higher rate of complete or partial response (OR 12.5, 95%CI 1.9–83.2, p-value < 0.05). There was no response in 8 (13.1%) patients, and 6 interrupted the treatments early. Only 2 patients suspended the HBOT due to a lack of clinical benefit. Conclusion: Our study supports using of HBOT as an adjunctive treatment for late-onset HC after allogeneic HSCT. Furthermore, 10 or more HBOT sessions delivered seem to impact the rate of HC resolution. Prospective, randomized, and well-controlled trials are needed to establish HBOT’s definitive efficacy and safety.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent1564728
dc.identifier.doi10.1038/s41598-024-74858-8
dc.identifier.issn2045-2322
dc.identifier.otherPURE: 102174185
dc.identifier.otherPURE UUID: 0b3f1954-c20e-46ff-817a-3408bf49aab7
dc.identifier.otherScopus: 85206872947
dc.identifier.otherPubMed: 39428542
dc.identifier.urihttp://hdl.handle.net/10362/174431
dc.identifier.urlhttps://www.scopus.com/pages/publications/85206872947
dc.language.isoeng
dc.peerreviewedyes
dc.subjectGeneral
dc.titleHyperbaric oxygen therapy in the treatment of late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantationen
dc.typejournal article
degois.publication.issue1
degois.publication.titleScientific Reports
degois.publication.volume14
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
s41598-024-74858-8.pdf
Tamanho:
1.49 MB
Formato:
Adobe Portable Document Format